Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 2
2010 1
2012 1
2013 2
2014 3
2015 3
2017 1
2018 2
2019 1
2020 1
2021 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Response.
Martinez-Quintanilla J, Shah K. Martinez-Quintanilla J, et al. J Natl Cancer Inst. 2014 Dec 2;107(1):370. doi: 10.1093/jnci/dju370. Print 2015 Jan. J Natl Cancer Inst. 2014. PMID: 25473105 No abstract available.
Oncolytic viruses: overcoming translational challenges.
Martinez-Quintanilla J, Seah I, Chua M, Shah K. Martinez-Quintanilla J, et al. J Clin Invest. 2019 Mar 4;129(4):1407-1418. doi: 10.1172/JCI122287. eCollection 2019 Mar 4. J Clin Invest. 2019. PMID: 30829653 Free PMC article. Review.
DPPA3-HIF1α axis controls colorectal cancer chemoresistance by imposing a slow cell-cycle phenotype.
Cuesta-Borràs E, Salvans C, Arqués O, Chicote I, Ramírez L, Cabellos L, Martínez-Quintanilla J, Mur-Espinosa A, García-Álvarez A, Hernando J, Tejedor JR, Mirallas O, Élez E, Fraga MF, Tabernero J, Nuciforo P, Capdevila J, Palmer HG, Puig I. Cuesta-Borràs E, et al. Among authors: martinez quintanilla j. Cell Rep. 2023 Aug 29;42(8):112927. doi: 10.1016/j.celrep.2023.112927. Epub 2023 Aug 1. Cell Rep. 2023. PMID: 37537841 Free article.
TET2 controls chemoresistant slow-cycling cancer cell survival and tumor recurrence.
Puig I, Tenbaum SP, Chicote I, Arqués O, Martínez-Quintanilla J, Cuesta-Borrás E, Ramírez L, Gonzalo P, Soto A, Aguilar S, Eguizabal C, Caratù G, Prat A, Argilés G, Landolfi S, Casanovas O, Serra V, Villanueva A, Arroyo AG, Terracciano L, Nuciforo P, Seoane J, Recio JA, Vivancos A, Dienstmann R, Tabernero J, Palmer HG. Puig I, et al. Among authors: martinez quintanilla j. J Clin Invest. 2018 Aug 31;128(9):3887-3905. doi: 10.1172/JCI96393. Epub 2018 Aug 6. J Clin Invest. 2018. PMID: 29944140 Free PMC article.
Antitumor therapy based on cellular competition.
Martinez-Quintanilla J, Cascallo M, Fillat C, Alemany R. Martinez-Quintanilla J, et al. Hum Gene Ther. 2009 Jul;20(7):728-38. doi: 10.1089/hum.2008.144. Hum Gene Ther. 2009. PMID: 19281300
Real-time multi-modality imaging of glioblastoma tumor resection and recurrence.
Hingtgen S, Figueiredo JL, Farrar C, Duebgen M, Martinez-Quintanilla J, Bhere D, Shah K. Hingtgen S, et al. Among authors: martinez quintanilla j. J Neurooncol. 2013 Jan;111(2):153-61. doi: 10.1007/s11060-012-1008-z. Epub 2012 Dec 16. J Neurooncol. 2013. PMID: 23242736 Free PMC article.
18 results